Catalyst Pharmaceutical
CPRX
CPRX
248 hedge funds and large institutions have $1.11B invested in Catalyst Pharmaceutical in 2023 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 83 increasing their positions, 83 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 46
25% less capital invested
Capital invested by funds: $1.47B → $1.11B (-$365M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
248
Holding in Top 10
3
Calls
$4.23M
Puts
$1.32M
Top Buyers
| 1 | +$25.7M | |
| 2 | +$11.2M | |
| 3 | +$6.61M | |
| 4 |
Barclays
London,
United Kingdom
|
+$6.3M |
| 5 |
RA
Royce & Associates
New York
|
+$5.7M |
Top Sellers
| 1 | -$29.1M | |
| 2 | -$15.6M | |
| 3 | -$14M | |
| 4 |
Two Sigma Advisers
New York
|
-$12.7M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$11.8M |